News
Molecular profiling could reduce both overtreatment and undertreatment of patients with high-intermediate risk endometrial ...
The global radiation oncology market size was US$ 7.7 billion in 2021. The global radiation oncology market size is estimated to reach US$ 15.1 billion by 2030, growing at a compound annual growth ...
OneOncology, a physician-led national platform supporting independent oncology practices, and its Monterey-based partner ...
The Phase 1/2a trial is a two-part, single-arm, prospective study aimed at determining the maximum tolerated dose (MTD), safety, and tolerability of REYOBIQ in pediatric patients aged 6 to 21 years ...
252160 Introduction: Positron Emission Tomography (PET) for real-time guidance in external beam radiation delivery is rapidly evolving. This approach enables more precise targeting by reducing beam ...
Five months after revealing results of a successful prostate cancer trial, Candel has shown more data from the study, bolstering the value of CAN-2409.
External beam radiation is the most common type of radiation therapy. It precisely targets cancer cells while minimizing damage to the surrounding area.
4monOpinion
ABP News on MSNOpinion: Advanced Radiation Therapy — Enhancing Precision And Efficiency In Cancer TreatmentBy Vidhi Prasad K.V. Advancements in radiation therapy have made this treatment a fundamental component of cancer care. An ...
The U.S. radiation oncology market is calculated at USD 6.65 billion in the year 2023, which grew at USD 7.19 billion in the year 2024 and is estimated to reach around USD 14.56 billion in the year ...
The two main types of radiation therapy for cancer are: External beam radiation therapy. A large machine aims radiation beams from outside your body to a cancer tumor from many angles.
With minimal exit dose, proton beam therapy might allow for decreased radiation exposure to the uninvolved hepatic parenchyma, potentially preserving long-term liver function. 6 These technological ...
External beam radiation therapy versus radical prostatectomy for high-risk prostate cancer: protocol of the RECOVER study. January 30, 2025 This paper describes the rationale and design of the RECOVER ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results